Reproducibility of gene expression across generations of Affymetrix microarrays.

Reliability and reproducibility issues in DNA microarray measurements. Trends Genet (2005) 6.79

Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements. BMC Bioinformatics (2005) 3.66

Hybridization interactions between probesets in short oligo microarrays lead to spurious correlations. BMC Bioinformatics (2006) 3.44

Joint analysis of two microarray gene-expression data sets to select lung adenocarcinoma marker genes. BMC Bioinformatics (2004) 2.73

Environmental whole-genome amplification to access microbial populations in contaminated sediments. Appl Environ Microbiol (2006) 2.24

Benchmarking the CATMA microarray. A novel tool for Arabidopsis transcriptome analysis. Plant Physiol (2005) 1.76

An online database for brain disease research. BMC Genomics (2006) 1.76

Combining gene expression data from different generations of oligonucleotide arrays. BMC Bioinformatics (2004) 1.53

Integrating probe-level expression changes across generations of Affymetrix arrays. Nucleic Acids Res (2005) 1.42

Quantifying the white blood cell transcriptome as an accessible window to the multiorgan transcriptome. Bioinformatics (2012) 1.10

"Hook"-calibration of GeneChip-microarrays: chip characteristics and expression measures. Algorithms Mol Biol (2008) 1.05

Development and validation of a flax (Linum usitatissimum L.) gene expression oligo microarray. BMC Genomics (2010) 1.04

Measuring global gene expression in polyploidy; a cautionary note from allohexaploid wheat. Funct Integr Genomics (2007) 1.01

CrossChip: a system supporting comparative analysis of different generations of Affymetrix arrays. Bioinformatics (2005) 1.01

Comparison of Affymetrix data normalization methods using 6,926 experiments across five array generations. BMC Bioinformatics (2009) 1.01

Associating phenotypes with molecular events: recent statistical advances and challenges underpinning microarray experiments. Funct Integr Genomics (2005) 0.96

The first decade and beyond of transcriptional profiling in schizophrenia. Neurobiol Dis (2011) 0.95

Microarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumors. BMC Cancer (2004) 0.93

Literature-aided meta-analysis of microarray data: a compendium study on muscle development and disease. BMC Bioinformatics (2008) 0.91

Integration of heterogeneous expression data sets extends the role of the retinol pathway in diabetes and insulin resistance. Bioinformatics (2009) 0.90

Identical probes on different high-density oligonucleotide microarrays can produce different measurements of gene expression. BMC Genomics (2006) 0.89

Generalization of DNA microarray dispersion properties: microarray equivalent of t-distribution. Biol Direct (2006) 0.86

Transformation of expression intensities across generations of Affymetrix microarrays using sequence matching and regression modeling. Nucleic Acids Res (2005) 0.86

Classification of unknown primary tumors with a data-driven method based on a large microarray reference database. Genome Med (2011) 0.82

Application of a correlation correction factor in a microarray cross-platform reproducibility study. BMC Bioinformatics (2007) 0.81

Bayesian models and meta analysis for multiple tissue gene expression data following corticosteroid administration. BMC Bioinformatics (2008) 0.81

Use of Bayesian networks to probabilistically model and improve the likelihood of validation of microarray findings by RT-PCR. J Biomed Inform (2008) 0.79

Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci U S A (1998) 192.97

Quantitative monitoring of gene expression patterns with a complementary DNA microarray. Science (1995) 88.48

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring. Science (1999) 83.27

Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol (1996) 72.84

Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci U S A (1996) 24.18

Analysis of variance for gene expression microarray data. J Comput Biol (2000) 16.28

A gene expression database for the molecular pharmacology of cancer. Nat Genet (2000) 13.31

Gene expression informatics--it's all in your mine. Nat Genet (1999) 12.35

Importance of replication in microarray gene expression studies: statistical methods and evidence from repetitive cDNA hybridizations. Proc Natl Acad Sci U S A (2000) 7.67

Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes. Cell (1999) 4.97

Normalization strategies for cDNA microarrays. Nucleic Acids Res (2000) 4.61

Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A (2002) 2.60

A new approach for filtering noise from high-density oligonucleotide microarray datasets. Nucleic Acids Res (2001) 1.54

Expression profiling reveals altered satellite cell numbers and glycolytic enzyme transcription in nemaline myopathy muscle. Proc Natl Acad Sci U S A (2003) 1.29

Identification of the genes responsive to etoposide-induced apoptosis: application of DNA chip technology. FEBS Lett (1999) 1.20

Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1. Proc Natl Acad Sci U S A (2003) 17.10

Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell (2012) 12.32

Clinical assessment incorporating a personal genome. Lancet (2010) 10.18

Managing incidental findings and research results in genomic research involving biobanks and archived data sets. Genet Med (2012) 9.65

Discovering statistically significant pathways in expression profiling studies. Proc Natl Acad Sci U S A (2005) 8.75

A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet (2006) 7.16

Performance comparison of exome DNA sequencing technologies. Nat Biotechnol (2011) 7.11

Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics (2002) 7.07

The Shared Health Research Information Network (SHRINE): a prototype federated query tool for clinical data repositories. J Am Med Inform Assoc (2009) 6.49

Ten years of pathway analysis: current approaches and outstanding challenges. PLoS Comput Biol (2012) 6.38

A mega-analysis of genome-wide association studies for major depressive disorder. Mol Psychiatry (2012) 6.34

Ontology-driven indexing of public datasets for translational bioinformatics. BMC Bioinformatics (2009) 6.31

Performance comparison of whole-genome sequencing platforms. Nat Biotechnol (2011) 5.79

Creation and implications of a phenome-genome network. Nat Biotechnol (2006) 5.79

Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci Transl Med (2011) 5.77

Medicine. Reestablishing the researcher-patient compact. Science (2007) 5.64

Tectonic shifts in the health information economy. N Engl J Med (2008) 5.42

Computational repositioning of the anticonvulsant topiramate for inflammatory bowel disease. Sci Transl Med (2011) 5.30

Multiple serotonergic brainstem abnormalities in sudden infant death syndrome. JAMA (2006) 5.10

Cell type-specific gene expression differences in complex tissues. Nat Methods (2010) 4.75

Sequence-matched probes produce increased cross-platform consistency and more reproducible biological results in microarray-based gene expression measurements. Nucleic Acids Res (2004) 4.43

An Environment-Wide Association Study (EWAS) on type 2 diabetes mellitus. PLoS One (2010) 4.42

Variant of SCN5A sodium channel implicated in risk of cardiac arrhythmia. Science (2002) 4.40

Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc Natl Acad Sci U S A (2005) 4.14

Cluster analysis of gene expression dynamics. Proc Natl Acad Sci U S A (2002) 3.83

Distinctive patterns of microRNA expression in primary muscular disorders. Proc Natl Acad Sci U S A (2007) 3.72

Stem and progenitor cells in skeletal muscle development, maintenance, and therapy. Mol Ther (2007) 3.69

Redefinition of Affymetrix probe sets by sequence overlap with cDNA microarray probes reduces cross-platform inconsistencies in cancer-associated gene expression measurements. BMC Bioinformatics (2005) 3.66

FoxO3 regulates neural stem cell homeostasis. Cell Stem Cell (2009) 3.54

Effects of RAS on the genesis of embryonal rhabdomyosarcoma. Genes Dev (2007) 3.45

Ribosomal protein L5 and L11 mutations are associated with cleft palate and abnormal thumbs in Diamond-Blackfan anemia patients. Am J Hum Genet (2008) 3.29

Expression-based genome-wide association study links the receptor CD44 in adipose tissue with type 2 diabetes. Proc Natl Acad Sci U S A (2012) 3.27

Network-based elucidation of human disease similarities reveals common functional modules enriched for pluripotent drug targets. PLoS Comput Biol (2010) 3.23

MAPPER: a search engine for the computational identification of putative transcription factor binding sites in multiple genomes. BMC Bioinformatics (2005) 3.23

Phased whole-genome genetic risk in a family quartet using a major allele reference sequence. PLoS Genet (2011) 3.20

Ribosomal protein S24 gene is mutated in Diamond-Blackfan anemia. Am J Hum Genet (2006) 3.17

ACTN3 genotype is associated with human elite athletic performance. Am J Hum Genet (2003) 3.12

Interferon-alpha/beta-mediated innate immune mechanisms in dermatomyositis. Ann Neurol (2005) 3.07

Abnormalities of the large ribosomal subunit protein, Rpl35a, in Diamond-Blackfan anemia. Blood (2008) 3.05

No small change for the health information economy. N Engl J Med (2009) 2.92

Challenges in the clinical application of whole-genome sequencing. Lancet (2010) 2.92

Systematic survey reveals general applicability of "guilt-by-association" within gene coexpression networks. BMC Bioinformatics (2005) 2.83

Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin. Nat Cell Biol (2005) 2.68

Hematopoietic stem cell quiescence is maintained by compound contributions of the retinoblastoma gene family. Cell Stem Cell (2008) 2.67

Gene expression comparison of biopsies from Duchenne muscular dystrophy (DMD) and normal skeletal muscle. Proc Natl Acad Sci U S A (2002) 2.60

Computerized recruiting for clinical trials in real time. Ann Emerg Med (2003) 2.59

Network-based analysis of affected biological processes in type 2 diabetes models. PLoS Genet (2007) 2.54

Exploiting drug-disease relationships for computational drug repositioning. Brief Bioinform (2011) 2.52

The tell-tale heart: population-based surveillance reveals an association of rofecoxib and celecoxib with myocardial infarction. PLoS One (2007) 2.52

Quantifying the relationship between co-expression, co-regulation and gene function. BMC Bioinformatics (2004) 2.51

Progressive histological damage in renal allografts is associated with expression of innate and adaptive immunity genes. Kidney Int (2011) 2.50

The SMART Platform: early experience enabling substitutable applications for electronic health records. J Am Med Inform Assoc (2012) 2.48

AILUN: reannotating gene expression data automatically. Nat Methods (2007) 2.47

A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors. Cancer Discov (2013) 2.46

MicroRNA profiling of human-induced pluripotent stem cells. Stem Cells Dev (2009) 2.44

Systematic evaluation of environmental factors: persistent pollutants and nutrients correlated with serum lipid levels. Int J Epidemiol (2012) 2.42

Translational bioinformatics: linking knowledge across biological and clinical realms. J Am Med Inform Assoc (2011) 2.36

Mutations in dynamin 2 cause dominant centronuclear myopathy. Nat Genet (2005) 2.33

Expression profiling and identification of novel genes involved in myogenic differentiation. FASEB J (2003) 2.30

A submission model for use in the indexing, searching, and retrieval of distributed pathology case and tissue specimens. Stud Health Technol Inform (2004) 2.28

Minimal haplotype tagging. Proc Natl Acad Sci U S A (2003) 2.28

Dynamic microRNA expression programs during cardiac differentiation of human embryonic stem cells: role for miR-499. Circ Cardiovasc Genet (2010) 2.24

Prediction of chronic obstructive pulmonary disease (COPD) in asthma patients using electronic medical records. J Am Med Inform Assoc (2009) 2.20

A nutrient-wide association study on blood pressure. Circulation (2012) 2.19

Conserved mechanisms across development and tumorigenesis revealed by a mouse development perspective of human cancers. Genes Dev (2004) 2.16

Exome sequencing identifies GATA1 mutations resulting in Diamond-Blackfan anemia. J Clin Invest (2012) 2.15

Comprehensive dissection of PDGF-PDGFR signaling pathways in PDGFR genetically defined cells. PLoS One (2008) 2.10

Non-synonymous and synonymous coding SNPs show similar likelihood and effect size of human disease association. PLoS One (2010) 2.10

Recessive truncating titin gene, TTN, mutations presenting as centronuclear myopathy. Neurology (2013) 2.09

The ribosomal basis of Diamond-Blackfan Anemia: mutation and database update. Hum Mutat (2010) 2.03

Leveraging models of cell regulation and GWAS data in integrative network-based association studies. Nat Genet (2012) 2.02

Somitic origin of limb muscle satellite and side population cells. Proc Natl Acad Sci U S A (2006) 2.01

The PING personally controlled electronic medical record system: technical architecture. J Am Med Inform Assoc (2004) 2.01

Rapid identification of myocardial infarction risk associated with diabetes medications using electronic medical records. Diabetes Care (2009) 2.00

Escaping the EHR trap--the future of health IT. N Engl J Med (2012) 1.96

Technical desiderata for the integration of genomic data into Electronic Health Records. J Biomed Inform (2011) 1.96

Autoimmune disease classification by inverse association with SNP alleles. PLoS Genet (2009) 1.96

An international effort towards developing standards for best practices in analysis, interpretation and reporting of clinical genome sequencing results in the CLARITY Challenge. Genome Biol (2014) 1.95

Disease signatures are robust across tissues and experiments. Mol Syst Biol (2009) 1.93

Finding the missing link for big biomedical data. JAMA (2014) 1.90

A self-scaling, distributed information architecture for public health, research, and clinical care. J Am Med Inform Assoc (2007) 1.88

Transcriptomic analysis of human lung development. Am J Respir Crit Care Med (2009) 1.87

Genome-scale expression profiling of Hutchinson-Gilford progeria syndrome reveals widespread transcriptional misregulation leading to mesodermal/mesenchymal defects and accelerated atherosclerosis. Aging Cell (2004) 1.87

T-tubule disorganization and defective excitation-contraction coupling in muscle fibers lacking myotubularin lipid phosphatase. Proc Natl Acad Sci U S A (2009) 1.83

In silico research in the era of cloud computing. Nat Biotechnol (2010) 1.81